| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |